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P24 B R I T I S H  O H R I A T R I C S  S O C I E T Y
QT DISPERSION IN HEALTHY YOUNG AND 63
ELDERLY VOLUNTEERS
MT KINIRONS, D LYONS, CG SWIFT and SHD JACKSON 
Clinical Age Research Unit, King’s College School of Medicine & 
Dentistry, London
BACKGROUND: QT dispersion (QTd) is determined from the 
measurement o f the minimum and maximum QTc for each lead o f a 
12 lead ECG. Increased QTd has been associated with increased 
cardiac mortality in patients with prolonged QT syndromes, chronic 
heart failure (CHF) (Barr et al. Lancet 1994;343:327-329.) and 
peripheral vascular disease (PVD) (Darbar et al. Br Med J 
1996;312:874-879). The effect o f age on QTd in healthy subjects 
however has not been examined. Therefore the aim of the study was 
to measure QTd in young healthy subjects and compare them to a 
healthy older cohort.
METHODS: Normal ECGs from 20 young (<40) and 20 elderly 
(>65) subjects were examined according to published methods for 
QTd (Barr et al. Lancet 1994;343:327-329.), All subjects were 
healthy as determined by hi story, examination, blood testing and 
ECG review, In the absence of published normal values and based on 
the young data, this study was designed with the power to detect a 
difference of 20% at the 5% level o f significance with 18 ECGs. 
Statistical analysis was by Mann-Whitney U  test. Results are given in 
milliseconds172 with mean ± SD followed by 95% confidence levels. 
RESULTS: No significant difference was detected between the 
young (60.2 ± 17,1 ms1/2; 52 ~ 68) and elderly (68.2 ± 29.5 ms1/2; 54 
- 83; p = 0.19) volunteers.
CONCLUSIONS: This is the first study to examine the effect of 
age as opposed to disease on QTd. There was no significant 
difference noted. However, a true difference of less than 20% can 
not be excluded on the basis of these data. All our subjects were 
healthy but occult coronary artery disease was not excluded. As 
QTd is increased in patients with CHF and PVD, if QTd is to be
useful as a sensitive and specific non-invasive tool for assessing the 
risk of cardiac death, then the finding of a lack of an age effect on 
QTd is important in further validating this novel measurement.
NASAL ABSORPTION OF 64
HYDROXOCOBALAMIN IN HEALTHY OLDER ADULTS
D. van Asselt, F. Merkus, W. Hoefnagels
Dept, of Geriatric Medicine, University Hospital Nijmegen,
PO Box 9101, 6500 HB Nijmegen, the Netherlands
Introduction: Cobalamin (Cbl) deficiency is very common 
among older people. Most physicians use intramuscular Cbl 
injections for treatment of Cbl deficiency. However, injections 
have many drawbacks, especially in older people. A more 
convenient and cost-effective alternative would be advantageous 
to medical practice.
Purpose: To determine the absorption o f nasally administered 
hydroxocobalamin (OH-Cbl) in an isotonic aqueous medium 
(patent nr WO 95/17164) in healthy older adults.
Design: In a cross-over study-design OH-Cbl, in a dose of 
750 ¡Xg and 1500 /¿g, was administered as nasal spray to 10 
healthy adults, age 71.6 ±  4.6 (mean ±SD ). Blood samples were 
collected before administration o f the drug and after 10, 20, 30, 
40, 60, 120, 180 and 240 minutes. Plasma Cbl concentration was 
determined by competitive radioisotope binding technique using 
purified hog intrinsic factor as binder.
Resultó: After nasal administration of 750 fig OH-Cbl the 
maximal plasma Cbl concentration ( C ^  and the time to reach 
the maximal plasma Cbl concentration (Trux) were 1943 ±  294 
pmol/1 (mean ±  SEM) and 32 ±  2 minutes, respectively. After 
nasal administration of 1500 jug OH-Cbl the Cnuix and Tmwc were 
3730 ±  807 pmol/1 and 28 ±  5 minutes, respectively. After 
administration of 750 fxg and 1500 ^g OH-Cbl the increase from 
baseline to maximum plasma Cbl concentration was 1663 ±  292 
pmol/1 and 3494 ±815 pmol/1, respectively. The nasal spray was 
well tolerated and no side effects were noted.
Conclusions: Nasal absorption of hydroxocobalamin is fast, high 
and safe. The amount absorbed increases with increasing dose of 
hydroxocobalamin.
REDUCED PLASMA VITAMIN B12 LEVELS 6 5
IN OLDER PATIENTS: A STATE OF B12 DEFICIENCY
D. van Asselt, H, Blom, R, Zuiderent, R. Wevers, C. Jakobs,
W, van den Broek, C. Lamers, F.Corstens, W. Hoefnagels
The Dept, of Geriatric Medicine, University Hospital Nijmegen,
PO Box 9101, 6500 HB Nijmegen, The Netherlands
Background: Reduced vitamin B12 levels are very common in 
older hospital patients. Most of them have normal blood counts. 
These low B12 levels are often considered to have no clinical 
significance or are simply ignored. Objective: To determine 
whether older patients with reduced B12 levels are B12 
deficient, B12 deficiency was considered present when a cause 
or a sign of B12 deficiency or a response to B12 administration 
could be identified, Methods: 28 older hospital patients with 
reduced plasma B12 levels were studied: 23% had B12 levels 
<75 pmol/L, 27% had B12 levels between 75-100 pmol/L and 
50% had B12 levels between 100-160 pmol/L. Two patients 
with anaemia are not included here since they are likely to be 
considered B12 deficient. Free and protein-bound B12 absorp­
tion were assessed. Haematologic, neurologic and metabolic 
(plasma methylmalonic acid and total homocysteine levels) 
measurements were obtained. 17 patients could be evaluated 
after parenteral B12 administration. Findings: Causes of B12 
deficiency, i.e. B12 malabsorption, were identified in 81 %,
Signs of B12 deficiency were identified in 96%: macrocytosis in 
15%, hypersegmented neutrophils in 54%, neurologic 
abnormalities in 31%, and elevated metabolite levels in 88%.
All patients available for follow-up had a haematologic or 
metabolic response to B12 administration. Therefore, all 3 
criteria of B12 deficiency were fulfilled by 65%, 2 criteria were 
fulfilled by 21% and 1 criterion by only 8%.Interpretation:
Older patients with reduced B12 levels are B12 deficient and 
should receive B12 therapy.
